S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference44 articles.
1. S-1-based non-S-1-based chemotherapy in advanced gastric cancer: a meta-analysis;Jian Yang;World J. Gastroenterol.,2014
2. A multicenter phase II study of biweekly paclitaxel and S-1combination chemotherapy for unresectable or recurrent gastric cancer;Aridome;Cancer Chemother. Pharmacol.,2008
3. Treatment of early gastric cancer in the Western World;Elfriede Bollschweiler;World J. Gastroenterol.,2014
4. Current role of minimally invasive approaches in the treatment of early gastric cancer;Abraham El-Sedfy;World J. Gastroenterol.,2014
5. The efficacy and toxicity of paclitaxel plus S-1 compared with paclitaxel plus 5-Fu for advanced gastric cancer;Huan Liu;Medicine,2014
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of docetaxel plus S-1-based therapy in gastric cancer: a quantitative evidence synthesis of randomized controlled trials;Frontiers in Pharmacology;2024-01-08
2. Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial;Nature Communications;2024-01-02
3. The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study;BMC Cancer;2022-11-28
4. Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study);Therapeutic Advances in Medical Oncology;2022-01
5. Treatment of Synchronous Liver Metastases from Gastric Cancer: A Single-Center Study;Cancer Management and Research;2020-08
Treatment of Synchronous Liver Metastases from Gastric Cancer: A Single-Center Study
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3